ORYZON GENOMICS, S.A. «12345...» Página 4 de 11 desde 01/07/1988 hasta 27/09/2024 30/07/2018 18:02 ORYZON GENOMICS, S.A. Interim financial information La sociedad remite información sobre los resultados del primer semestre de 2018 Número de registro: 268660 29/05/2018 07:37 ORYZON GENOMICS, S.A. R&D: new licenses, patents and registered trademarks Approval by the UK Medicines Agency (MHRA) of the commencement of a Phase IIa clinical trial regarding ORY-2001. Número de registro: 266182 16/05/2018 19:51 ORYZON GENOMICS, S.A. Shareholders agreements affecting voting rights Termination Notice of the shareholders’ agreement entered into by Mr. Carlos Manuel Buesa Arjol, Mr. José María Echarri Torres and Mrs. Tamara Maes and Najeti Capital, S.A.U. Número de registro: 265740 Relacionado con 232306 del 14/12/2015 (19:26) 09/05/2018 07:48 ORYZON GENOMICS, S.A. Interim financial information La sociedad remite información sobre los resultados del primer trimestre de 2018 Número de registro: 265356 08/05/2018 08:01 ORYZON GENOMICS, S.A. R&D: new licenses, patents and registered trademarks Approval by the French Medicines Agency (ANSM) of the commencement of a Phase IIA clinical trial regarding ORY-2001. Número de registro: 265282 04/04/2018 20:39 ORYZON GENOMICS, S.A. Announcements and resolutions of general shareholders meetings Oryzon Genomics, S.A. informs about the resolutions passed by the Ordinary General Shareholders’ Meeting. Número de registro: 263738 Relacionado con 262494 del 02/03/2018 (08:32) 04/04/2018 08:04 ORYZON GENOMICS, S.A. R&D: new licenses, patents and registered trademarks Approval by the Spanish Medicines Agency (AEMPS) of the commencement of a Phase IIA clinical trial regarding ORY-2001. Número de registro: 263634 02/03/2018 08:32 ORYZON GENOMICS, S.A. Announcements and resolutions of general shareholders meetings Call of the Ordinary General Shareholders’ Meeting of Oryzon Genomics, S.A. Número de registro: 262494 Relacionado con 263738 del 04/04/2018 (20:39) 20/02/2018 11:57 ORYZON GENOMICS, S.A. Board of directors remuneration annual statement La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2017 Número de registro: 261741 19/02/2018 22:50 ORYZON GENOMICS, S.A. Composition of the board of directors The Company announces changes in the composition of the Board of Directors. Número de registro: 261727 Rectificado por 261726 del 19/02/2018 (22:31) Página 4 de 11 «12345...»